Overview

Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety of the drug Etanercept (Enbrel) and to determine if this drug can help in the treatment of early bone marrow failure in patients with Fanconi anemia.
Phase:
Early Phase 1
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborator:
Amgen
Treatments:
Etanercept